  In this review we address to what extent computational techniques can augment
our ability to predict toxicity. The first section provides a brief history of
empirical observations on toxicity dating back to the dawn of Sumerian
civilization. Interestingly, the concept of dose emerged very early on, leading
up to the modern emphasis on kinetic properties, which in turn encodes the
insight that toxicity is not solely a property of a compound but instead
depends on the interaction with the host organism. The next logical step is the
current conception of evaluating drugs from a personalized medicine
point-of-view. We review recent work on integrating what could be referred to
as classical pharmacokinetic analysis with emerging systems biology approaches
incorporating multiple omics data. These systems approaches employ advanced
statistical analytical data processing complemented with machine learning
techniques and use both pharmacokinetic and omics data. We find that such
integrated approaches not only provide improved predictions of toxicity but
also enable mechanistic interpretations of the molecular mechanisms
underpinning toxicity and drug resistance. We conclude the chapter by
discussing some of the main challenges, such as how to balance the inherent
tension between the predictive capacity of models, which in practice amounts to
constraining the number of features in the models versus allowing for rich
mechanistic interpretability, i.e. equipping models with numerous molecular
features. This challenge also requires patient-specific predictions on
toxicity, which in turn requires proper stratification of patients as regards
how they respond, with or without adverse toxic effects. In summary, the
transformation of the ancient concept of dose is currently successfully
operationalized using rich integrative data encoded in patient-specific models.
